Appropriate antimicrobial use during the COVID-19 pandemic: not cause for complacency
Lancet Microbe
.
2023 May;4(5):e293.
doi: 10.1016/S2666-5247(23)00061-7.
Epub 2023 Mar 15.
Authors
Nikolaos Spernovasilis
1
,
Aris P Agouridis
2
,
Constantinos Tsioutis
3
Affiliations
1
Department of Infectious Diseases, German Oncology Center, Limassol, Cyprus; School of Medicine, University of Crete, Heraklion, Greece.
2
School of Medicine, European University Cyprus, Nicosia, Cyprus; Department of Internal Medicine, German Oncology Center, Limassol, Cyprus.
3
School of Medicine, European University Cyprus, Nicosia, Cyprus. Electronic address: k.tsioutis@euc.ac.cy.
PMID:
36933564
PMCID:
PMC10017110
DOI:
10.1016/S2666-5247(23)00061-7
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Infective Agents* / therapeutic use
COVID-19*
Humans
Pandemics
Substances
Anti-Infective Agents